Rituximab to Treat Neuropathy With Anti-MAG Antibodies

NCT00050245 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Polyneuropathies

Interventions

DRUG: Rituximab

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)